March 2018
Current status of human immunodeficiency virus and hepatitis C virus (HIV/HCV) co-infection in Cameroon: Sero-prevalence, risk factors and correlation with markers of liver function and CD4 cells rate in patients diagnosed in three hospital settings
This study investigates the current status of HIV/HCV co-infection through viral sero-prevalence and correlation with liver markers and CD4 count in three hospital settings in Cameroon. Blood samples of 75 newly diagnosed HIV patients, and 546 people attending the target hospitals were screened for HCV(antigen-antibodies) using enzyme-immunoassay. Biochemical liver markers (ALT-AST-g-GT-Bilirubin) and CD4-cell count...
March 2018
Time for initiation of antiretroviral therapy in HIV co-infected tuberculosis patients in Addis Ababa, Ethiopia
Provision of integrated care for human immunodeficiency virus (HIV) co-infected tuberculosis (TB) patients is challenging. Many persons with TB and HIV co-infection are not yet receiving anti-retroviral therapy (ART) and initiation of ART is not always timely. This study investigated ART uptake among HIV co-infected TB patients and its time of initiation in an urban primary health care facility in Ethiopia. A...
March 2018
Pattern and predictors of cluster of differentiation 4 (CD4) cell count recovery among cohorts of human immunodeficiency virus (HIV)-infected patients on antiretroviral therapy in Hawassa University Referral Hospital
Cluster of differentiation 4 (CD4) cell count recovery is used in determining disease progression and outcome monitoring. This study was conducted to determine the trends of CD4 cell count recovery, and its determinants in Hawassa university referral hospital, Ethiopia. Retrospective cohort study design was employed to gather relevant data among human immunodeficiency virus (HIV) positive-patients visiting Hawassa...
Advertisement
Advertisement